Potassium paraaminobenzoate vs placebo
It is very uncertain whether potassium paraaminobenzoate changes discontinuation from treatment compared with placebo (very low certainty).
- RR 1.36 [0.72, 2.58]1 study · 103 participantsVery low
It is very uncertain whether potassium paraaminobenzoate changes discontinuation from treatment compared with placebo (very low certainty).
It is very uncertain whether penile traction therapy changes discontinuation from treatment compared with no treatment (short‐term) (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether shock wave lithotripsy changes stone‐free rate compared with dissolution therapy (very low certainty).
It is very uncertain whether shock wave lithotripsy changes serious adverse events or complications of treatment compared with ureteroscopy with holmium laser or pneumatic lithotripsy (very low certainty).
It is very uncertain whether shock wave lithotripsy changes second procedures compared with ureteroscopy with holmium laser or pneumatic lithotripsy (very low certainty).
Shock wave lithotripsy probably leads to lower stone‐free rate compared with mini‐percutaneous nephrolithotripsy (moderate certainty).
Shock wave lithotripsy may leads to lower serious adverse events or complications of treatment compared with mini‐percutaneous nephrolithotripsy (low certainty).
Shock wave lithotripsy may leads to higher secondary procedures compared with mini‐percutaneous nephrolithotripsy (low certainty).
It is very uncertain whether percutaneous nephrolithotripsy changes stone‐free rate compared with tubeless percutaneous nephrolithotripsy (very low certainty).
It is very uncertain whether percutaneous nephrolithotripsy changes serious adverse events or complications of treatments compared with tubeless percutaneous nephrolithotripsy (very low certainty).
It is very uncertain whether percutaneous nephrolithotripsy changes secondary procedures compared with tubeless percutaneous nephrolithotripsy (very low certainty).
It is very uncertain whether shock wave lithotripsy changes serious adverse events or complications of treatment compared with dissolution therapy (very low certainty).
Percutaneous nephrolithotripsy showed no clear difference in stone‐free rate compared with tubeless mini‐percutaneous nephrolithotripsy (moderate certainty).
The review found no eligible studies for this question.